Greg Harrison analyst BAML

Currently out of the existing stock ratings of Greg Harrison, 33 are a BUY (66%), 12 are a HOLD (24%), 5 are a SELL (10%).

Greg Harrison

Work Performance Price Targets & Ratings Chart

Analyst Greg Harrison works at BAML with a stock forecast success ratio of 58.85% fulfilled within 93.81 days on average.

Greg Harrison’s has documented 93 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LQDA, Liquidia Technologies at 21-Dec-2023.

Wall Street Analyst Greg Harrison

Analyst best performing recommendations are on OMER (OMEROS).
The best stock recommendation documented was for OMER (OMEROS) at 11/8/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.2 (6.25%) receiving and performance score of 62.5.

Average potential price target upside

ATHX Athersys NKTR Nektar Therapeutics RCKT Rocket Pharmaceuticals TVTX Travere Therapeutics AGIO Agios Pharm RDUS Schnitzer Steel Industries STOK Stoke Therapeutics OMER Omeros EDIT Editas Medicine NLTX Neoleukin Therapeutics LQDA Liquidia Technologies BBIO BridgeBio Pharma ISEE IVERIC bio BEAM Beam Therapeutics  UTHR United Therapeutics NTLA Intellia Therapeutics SGMO Sangamo Therapeutics

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$6.24 (62400.00%)


2 years 3 days ago

1/3 (33.33%)

$0.9 (16.82%)




3 years 3 months 9 days ago

1/1 (100%)

$-23.25 (-67.88%)




$124.57 (28969.77%)

4 years 18 days ago

0/1 (0%)

$54 (76.06%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Greg Harrison is most bullish on?

Potential upside of $10.68 has been obtained for BEAM (BEAM THERAPEUTICS )

Which stock is Greg Harrison is most reserved on?

Potential downside of $2.58 has been obtained for LQDA (LIQUIDIA TECHNOLOGIES)

What Year was the first public recommendation made by Greg Harrison?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?